Ocular Therapeutix (OCUL) Tops Q2 EPS by 3c

Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Raymond James Reiterates Underperform Rating on Lennar (LEN)
• Evercore lifts Ciena rating on AI-driven optical networking boom